Delhi High Court Refuses Interim Injunction Against RTPCR Testing Kit OMISURE - (01 Apr 2022)
INTELLECTUAL PROPERTY RIGHTS
Delhi High Court has refused to pass an ad interim injunction against Tata Medical and Diagnostics Limited, manufacturer of OMISURE, an RTPCR kit that was used to detect COVID-19 Omicron variant, in a suit filed by Mankind Pharma Limited seeking permanent injunction for infringement of trademark
Tags : DELHI HIGH COURT AD INTERIM INJUNCTION TATA MEDICAL AND DIAGNOSTICS LIMITED OMISURE COVID-19 OMICRON VARIANT MANKIND PHARMA
Share :
![](/newsroom/images/whatsapp.png)
|